Erik H Vogelzang

Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies

Laura Boekel, Maurice Steenhuis, Femke Hooijberg et al. · The Lancet Rheumatology · 2021 · 170 citations · Full text

Perspective of patients with autoimmune diseases on COVID-19 vaccination

Laura Boekel, Femke Hooijberg, Zoé L. E. van Kempen et al. · The Lancet Rheumatology · 2021 · 91 citations · Full text

Anti-adalimumab antibodies and adalimumab concentrations in psoriatic arthritis; an association with disease activity at 28 and 52 weeks of follow-up

Erik H Vogelzang, E. Kneepkens, Michael T. Nurmohamed et al. · Annals of the Rheumatic Diseases · 2014 · 79 citations

Development of a SARS-CoV-2 Total Antibody Assay and the Dynamics of Antibody Response over Time in Hospitalized and Nonhospitalized Patients with COVID-19

Erik H Vogelzang, Floris C. Loeff, Ninotska I. L. Derksen et al. · The Journal of Immunology · 2020 · 79 citations · Full text

Adverse events after first COVID-19 vaccination in patients with autoimmune diseases

Laura Boekel, Laura Kummer, Koos P J van Dam et al. · The Lancet Rheumatology · 2021 · 79 citations · Full text